In Vivo Detection of Activated Platelets Allows Characterizing Rupture of Atherosclerotic Plaques with Molecular Magnetic Resonance Imaging in Mice by von Elverfeldt, D et al.
In Vivo Detection of Activated Platelets Allows
Characterizing Rupture of Atherosclerotic Plaques with
Molecular Magnetic Resonance Imaging in Mice
Dominik von Elverfeldt1., Constantin von zur Muhlen2., Kristina Wiens2, Irene Neudorfer2,
Andreas Zirlik2, Mirko Meissner1, Peg Tilly3, Anne-Laure Charles3, Christoph Bode2, Karlheinz Peter4",
Jean-Etienne Fabre3*"
1Department of Radiology/Medical Physics, University Hospital, Freiburg, Germany, 2Department of Cardiology and Angiology I, University Heart Center, Freiburg,
Germany, 3 Institut de Ge´ne´tique et de Biologie Mole´culaire et Cellulaire (IGBMC), Institut National de Sante´ et de Recherche Me´dicale (INSERM) U964/Centre National de
Recherche Scientifique (CNRS) UMR 7104/Universite´ de Strasbourg, Illkirch, France, 4 Baker IDI Heart & Diabetes Institute, Melbourne, Australia
Abstract
Background: Early and non-invasive detection of platelets on micro atherothrombosis provides a means to identify unstable
plaque and thereby allowing prophylactic treatment towards prevention of stroke or myocardial infarction. Molecular
magnetic resonance imaging (mMRI) of activated platelets as early markers of plaque rupture using targeted contrast
agents is a promising strategy. In this study, we aim to specifically image activated platelets in murine atherothrombosis by
in vivo mMRI, using a dedicated animal model of plaque rupture.
Methods: An antibody targeting ligand-induced binding sites (LIBS) on the glycoprotein IIb/IIIa-receptor of activated
platelets was conjugated to microparticles of iron oxide (MPIO) to form the LIBS-MPIO contrast agent causing a signal-
extinction in T2*-weighted MRI. ApoE2/2 mice (60 weeks-old) were fed a high fat diet for 5 weeks. Using a small needle, the
surface of their carotid plaques was scratched under blood flow to induce atherothrombosis. In vivo 9.4 Tesla MRI was
performed before and repetitively after intravenous injection of either LIBS-MPIO versus non-targeted-MPIO.
Results: LIBS-MPIO injected animals showed a significant signal extinction (p,0.05) in MRI, corresponding to the site of
plaque rupture and atherothrombosis in histology. The signal attenuation was effective for atherothrombosis occupying
$2% of the vascular lumen. Histology further confirmed significant binding of LIBS-MPIO compared to control-MPIO on the
thrombus developing on the surface of ruptured plaques (p,0.01).
Conclusion: in vivo mMRI detected activated platelets on mechanically ruptured atherosclerotic plaques in ApoE2/2 mice
with a high sensititvity. This imaging technology represents a unique opportunity for noninvasive detection of
atherothrombosis and the identification of unstable atherosclerotic plaques with the ultimate promise to prevent strokes
and myocardial infarctions.
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Introduction
Cardiovascular diseases are still a major factor of mortality and
morbidity [1] in developed countries and are emerging as a major
health care problem in developing countries. Early detection of
atherothrombosis would improve the management of acute
coronary diseases.
The majority of fatal myocardial infarctions are caused by
disruption of the fibrous cap that covers atherosclerotic plaques.
Subsequent exposure of molecules such as von Willebrandt Factor
and collagen mediate platelet adhesion and activation, leading to
thrombosis. Depending on local factors, such as the size of the
rupture or the inflammatory status of the plaque [2], thrombosis is
limited or conversely becomes obstructive. It is therefore highly
desirable to detect early non-obstructive thrombosis before it
induces myocardial infarction or stroke. Indeed timely angioplasty
is beneficial in non-ST elevation acute coronary syndrome [3],
and identifying ruptured lesions, which have not yet resulted in
occlusive disease, could help in patient management.
Contrary to conventional angiography [4], PET-CT imaging
with fluordeoxyglucose allows detection of inflammatory processes
in rupture-prone atherosclerotic plaques [5]. However, this
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approach is limited by a poor spatial resolution and does not
indicate whether the plaque has already ruptured and initiated
limited thrombosis. In this context, MRI with specific contrast
agents [6] is of high interest. Indeed, MRI characterizes plaques
[7] and molecular contrast agents can target cellular receptors
activated by atherothrombosis [8]. One molecular determinant of
activated platelets is the highly abundant and uniquely specific
integrin aIIbß3. We recently described a MRI contrast agent
targeting ligand-induced binding sites (LIBS) of the activated
integrin aIIbß3 [9,10,11,12], which thereby targets specifically
activated platelets.
The efficiency of this platelet-targeting strategy to image
activated platelets has been demonstrated in a proof of concept
approach using an in vivo model of ferric chloride-induced
thrombosis in the carotid artery of mice [9]. However, it is not
known whether this strategy can detect atherothrombosis, and
whether sensitivity would be sufficient.
We are now providing data demonstrating that this platelet
targeting approach can be used in magnetic resonance imaging to
identify small thrombi occurring on in vivo ruptured atherosclerotic
plaques. This technology provides a unique perspective towards
the imaging of unstable atherosclerotic plaques.
Methods
Construction of the MRI Contrast Agent Specific for
Activated Platelets
The monoclonal antibody (mAb) anti-LIBS 145 binds to aIIbß3
only in its active conformation [13]. Cloning, generation and
production of the single-chain antibody anti-LIBS 145 has been
described in detail elsewhere [14]. The generation and purification
of the irrelevant control single-chain antibody was also described
elsewhere [15].
The contrast agent was constructed using autofluorescent
cobalt-functionalised MPIOs (sized 1 mm, Dynal Biotech, Oslo,
Norway) conjugated with the histidine-tag of the LIBS/control
single-chain antibody [9,11]. A magnet was used to separate
unbound from MPIO-bound antibody.
Animal Model
Our studies are in compliance with the position of American
Heart Association on research animal use. This study followed the
national guidelines, and was approved by the institutional animal
care committee of the University of Freiburg, Germany (permit
No. 35/9185.81/G-09/47).
ApoE2/2 mice aged of 60 weeks and fed a high fat diet for 5
weeks were anesthetized with isoflurane. A venous catheter with a
120 cm long tube (Portex, Smiths Medical International, USA)
was placed in the tail vein. A 30-gauge needle with its bended tip
was introduced through a branch in the external carotid and
advanced up to a plaque. The tip was applied to the plaque to
scratch its surface [2]. The collateral artery was ligated, the wound
sutured and 8 units of heparin were injected to prevent vessel
occlusion.
In Vivo Experimental and MRI Protocol of Contrast Agent
Injection
Mice were consecutively and randomly assigned to either LIBS-
MPIO or control-MPIO group before performing the MRI. The
mice were placed in the custom made animal bed, connected to an
ECG and breathing-rate monitor, and transferred to the MRI
system, a 94/20 Bruker BioSpec, Bruker, Germany.
The body temperature and breathing rate were continuously
monitored. MRI was performed employing a quadrature whole
body birdcage resonator (35 mm inner diameter) and the
following imaging protocol.
After an iterative 1st and 2nd order shimming routine the
geometry of a coronal, ECG triggered 2D-FLASH (TE/TR:
4.4 ms/250 ms) with 15 slices was adjusted on a standard
FLASH based multi slice pilot scan to be in plane with the
course of the common carotid arteries. Perpendicular to these
images a 3D-FLASH (Matrix: 2566256664) with TE/TR:
2.8 ms/20 ms, a flip angle of 25u, a bandwidth of 55 kHz, 2
averages, and a field of view of 2762769 mm3 resulting in a
voxel resolution of 10561056141 mm3 and a total scan time of
8 min 11 s was run. This sequence was optimised to achieve a
highly hyperintense blood signal from the carotid arteries. The
injection was performed only when the hyperintense blood
signal was identified.
Quantification of MPIO-induced Signal Void
Image evaluation was MatlabH based, as described elsewhere
(9). In brief, we calculated for each time point the quotient of mean
signal intensity of the ROI in the vessel with plaque-rupture
divided by the mean of the ROI in the contralateral, non-injured
vessel. These quotients were then normalized on the baseline 3D
FLASH starting value, gaining a time series of the fractional
amount of remaining signal after contrast agent injection.
Tissue Harvesting and Histology
After performing in vivo MRI, animals were euthanized and
perfused throught the left ventricle with saline. The injured and
contralateral carotid artery were embedded in OCT TissueTec
(Sakura Finetec, Netherlands) and frozen for histology. Throm-
bosis was quantified through immunodetection of platelets using
rat anti-mouse glycoprotein IIb (CD41) polyclonal antibody
(Clone MWReg30, GeneTex, USA), followed by a rabbit anti-
rat biotinylated secondary antibody (Vectastain ABC-AP and
VectorRed, Vector, Germany). On nine representative sections
covering the scratched area of the plaque, thrombus size was
quantified in percent of the total vessel lumen using Axiovision
Software (Carl Zeiss, Germany). The same sections were used to
count the number of MPIOs and the average per section,
covering the volume of the superimposed thrombus was
calculated. Furthermore, plaque size was measured in percent
of total vessel lumen in the same sections, and averaged for
each animal. One subset of sections was also stained using a
standard Masson-Trichrome protocol.
Statistics
The in vivo-protocol was performed in 20 mice, 16 of which
received LIBS-MPIO and 4 received control-MPIO as contrast
agent. The complexity of our animal model led to exclude 9 LIBS-
MPIO animals from the statistical analysis. In 7 animals, the
exclusion was decided on the baseline scan. In 5 cases the induced
thrombus had completely occluded the vessel. In 2 cases a signal
void in the contra lateral vessel was observed, and histology indeed
showed local occlusion. Finally one animal died during contrast
agent injection and for one animal the histological data where lost
due to significant problems processing the tissue.
Statistics tests were finally performed on 11 mice (n = 7 for
LIBS-MPIO; n= 4 for control-MPIO), using a standardized t-test
(MRI signal attenuation and histological MPIO counts) or
Pearson’s test (correlation analyses). Differences were considered
significant when p,0.05, as calculated with Microsoft ExcelTM.
MR Imaging of In Vivo Atherothrombosis in Mice
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Results
Mechanical Plaque Rupture and Atherothrombosis
In all included animals (n = 11), plaques were successfully
scratched (Fig. 1). Histology performed in these animals assessed
the presence of thrombosis (Fig. 1C). In average, the thrombus
occupied 4.8362.73% of the lumen in the group of mice that
received LIBS-MPIO (n= 7) and 3.0860.02% in the control
animals receiving control-MPIO (n= 4).
Injection of LIBS-MPIO Reduced the MR Signal Only on
the Ruptured Side
In all scratched and included animals, the white MR signal (red
circle) induced by flowing blood in transversal sections of the
carotid artery is clearly visible before the injection (Fig. 2, time
points t(21)). After the injection, LIBS-MPIOs attenuated the
signal in the injured external carotid artery (Fig. 2A, time points t2
and t3). This is well visible in the second, third and fourth
transversal section/column, which corresponds to the developing
thrombus in histology. No signal extinction is seen in the non-
injured internal carotid artery (green circle). In animals receiving
control-MPIO (Fig. 2B), the same procedure failed to attenuate
the signal, suggesting that the non-specific contrast agent did not
bind at the site of plaque ruptures.
These examples indicate that only LIBS-MPIOs extinguished
the MR signal and only on the injury side, which strongly suggest
that LIBS-MPIOs recognized activated platelets in atherothrom-
bosis.
The Threshold for Detecting Ruptured Plaques with
Superimposed Thrombus by LIBS-MPIO is 2% of the
Vessel Lumen
Since the induced thrombus showed large variations in size due
to the intrinsic properties of plaques, we analysed the animals in
two sub-groups defined by their thrombus size above or below 2%
of the total vessel lumen. The averaged thrombus size in the group
of animals with thrombosis occupying more than 2% of the artery
lumen was 8.46%62.93%, while thrombosis occupied only
1.2%60.22% in the other group.
The subgroup analysis of animals with thrombus size comprised
between 21% and 2% of the carotid lumen is shown in Fig. 3A for
animals with LIBS-MPIO and control-MPIO injection. At each
time point after the injection of LIBS-MPIO, the MR signal
detected at the level of the scratched plaque was lower than the
signal detected at the level of the contralateral and non-injured
plaque (Fig. 3A, red line). Conversely, the ratio of signals increased
after the injection of control-MPIO (Fig. 3A, blue line).
In animals in which the thrombus had been limited to 2% of the
lumen, the signal ratio had not been altered by the injection of
LIBS-MPIO, as compared to the injection of control-MPIO
(Fig. 3B).
Therefore, we can conclude that LIBS-MPIO attenuated the
MR signal specifically on the injured side and that 2% thrombus
size in relation to total vessel lumen appears to be the threshold for
reliable detection in this model.
Figure 1. The experimental design. (A) Cartoon depicting the model used for inducing atherothrombosis. A tiny curved needle introduced
through a branch of the external carotid was advanced up to the plaque surface under persistent blood flow. After positioning the tip of the needle
in front of the plaque, it was applied to the plaque and moved forth and back twice in order to scratch the fibrous cap. (B) The experimental timeline.
‘‘I’’ stands for injection. (C) Transversal histological section of the carotid artery after the scratch injury. Immunohistochemistry depicts platelets and
therefore thrombus in red. The scratch with superimposed thrombosis is clearly visible and induced here a small dissection (arrow). A corresponding
section of the site of the plaque rupture stained with Masson-Trichrome is depicted in (D).
doi:10.1371/journal.pone.0045008.g001
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MPIOs were Located on the Injured Side
MPIOs could be identified on histological slides, as shown on
Fig. 4. We counted and averaged the number of MPIOs found in 5
histological sections representing the whole thrombus volume in
each animal. As shown in Fig. 5A, MPIOs were about four-fold
more abundant in slices from animals receiving LIBS-MPIO as
compared to the animals receiving control-MPIO (16.2562.4 vs.
4.2561.0 per section, p,0.01).
A similar difference was observed between injured and non
injured carotids in animals receiving LIBS-MPIO (Fig. 5B:
16.2562.4 vs. 5.9061.0 per section, p,0.01).
We calculated the number of MPIOs needed to attenuate the
signal. Given a relaxivity r2* of 494 L.mmol
21.s21, an echo time of
2.8 ms, a vessel diameter of 420 mm, a thrombus occupying 15%
of the lumen, and a histological slice thickness of 10 mm, 11.3
MPIOs in average are needed to decrease the signal by 30%.
Based on this calculation, the 16.25 MPIOs in average found on
histological slices explain well the signal attenuation seen on MRI
acquisitions.
Altogether, our data show that injected LIBS-MPIOs recog-
nized specifically fresh atherothrombosis, attenuated the MR
signal and thereby can be used to detect even moderate
atherothrombosis provided that it occupies more than 2% of the
vascular lumen.
Discussion
Our present results show that atherothrombosis triggered by the
mechanical rupture of atherosclerotic plaques was specifically
detected by LIBS-MPIO, as assessed by the significant higher
number of MPIO on histological slices, which diminished the MR
signal through the paramagnetic property of iron oxide.
In previous studies, the injection of LIBS-MPIO in mice
decreased the blood flow MRI signal in carotid arteries where
thrombosis had been induced by ferric chloride, while a
subsequent thrombolytic treatment restored the signal [9]. Because
thrombosis in this model is associated with a substantial thrombus
load and is stable, it was necessary to test whether this strategy can
detect atherothrombosis in vulnerable plaques, in which throm-
bosis might be limited and labile.
We used 60-weeks old ApoE2/2 mice in which plaques
developed slowly under chow-fed, allowing the formation of
Figure 2. Axial MRI images of the external carotid arteries from two representative animals. Depicted are four consecutive slices (H1-H4)
at three time points: t(21) (before injection), t2 (16 minutes after injection) and t3 (24 minutes after injection). Red circles indicate the left external
carotid artery which underwent surgery and scratching of the plaque, and green circles mark the contra lateral vessel. The animals orientation is
indicated by labeling its posterior (P) and left (L) direction. Signal attenuation can be observed in the animal A which received LIBS-MPIO contrast
agent whereas the blood signal remains hyperintense in animal B receiving the control-MPIO.
doi:10.1371/journal.pone.0045008.g002
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fibrous cap. We then subjected these mice to high fat diet for 5
weeks in order to exacerbate inflammation in the plaque [16] and
thereby the plaque thrombogenicity [2]. To induce atherothrom-
bosis, we scratched carotid plaques, because the limited resulting
injury is well-suited to test the hypothesis that nascent thrombosis
can be detected in vivo by MRI using the LIBS strategy. The
LIBS-antibody specifically detects the activated glycoprotein IIb/
IIIa-receptor on the surface of activated platelets, and thereby
detects developing thrombi. This method is highly sensitive,
because the large sizes of the microparticles combined with a high
payload of iron allow just a few single MPIO to alter the MRI
signal [17,18].
We observed that the MR signal was diminished following the
LIBS-MPIO injection, while histology showed that atherothrom-
bosis had been induced by the scratch. By contrast, we should not
observe any change in the ratio of injured/non injured carotid
signals in mice receiving control-MPIO. In fact, the ratio increased
(Fig. 3, blue lines). This effect can be explained by fibrinolysis of
the thrombus that ultimately detached from the vessel wall under
the pressure of blood flow. As a consequence the flow increased
and augmented the MR-signal. This effect occurred also in
animals that had received LIBS-MPIO; however, the MPIOs
trapped in the remaining thrombus were sufficient to cause a
significant signal decrease.
The paramagnetic effect of iron was linked to the presence of
iron oxide particles in atherothrombosis, as shown by histology.
We were not surprised to observe some baseline uptake after
control-MPIO injection (Fig. 5A), because forming atherothrom-
bosis can non-specifically entrap some of these particles. However,
their number was not sufficient to cause a relevant signal loss. In
addition, we observed some particles on the surface of the non-
injured contralateral atherosclerotic plaques (Fig. 5B), also unable
to extinct the MRI signal. The histological analysis confirmed the
absence of relevant atherothrombosis (.2%) on the uninjured
sides; it is however possible that these particles have been
entrapped in minor platelet aggregations occurring at the surface
Figure 3. Quantitative analysis of MRI data. Subgroup analysis of animals with thrombus size .2% is shown in Fig. 3A for animals with LIBS-
MPIO and control-MPIO injection. At each time point after the injection of LIBS-MPIO, the MR signal detected at the level of the scratched plaque was
significantly lower than the signal detected at the contralateral and non-injured plaque level (A, red line). Conversely, the ratio of signals slightly
increased after the injection of control-MPIO (A, blue line). In animals with thrombus size ,2%, the signal ratio had not been altered by the injection
of LIBS-MPIO in comparison to the injection of control-MPIO (3B).
doi:10.1371/journal.pone.0045008.g003
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of inflamed and unstable plaques, especially after the 5-weeks of
high fat diet [19,20].
Although the circulation-time for large MPIOs is very short and
they are taken up rapidly by the liver and the spleen, MPIOs are
even present in significant numbers after 72 min total circulation
time (unpublished data). Particles can therefore bind over a long
period of time, which explains that we even observe an increase in
signal intensity as demonstrated in figure 3. As long as the particles
have not bound and accumulated at the site of the thrombus, their
contrast effects only average to a slight shortening of T2* of the
blood signal. In the images, this effect is negligible due to the
sequence-related strong enhancement of inflowing blood as seen in
the contralateral carotid artery and in the images using control-
MPIO. However, signal evaluation still accounts for this effect by
Figure 4. Histological identification of MPIOs. (A): Representative anti-CD41 immunostaining of a carotid artery section from a mouse receiving
LIBS-MPIOs. (B) Enlargement of the area from (A) shows MPIOs inside the thrombus (circles). MPIOs can be recognized as regular round structures
with a blue halo and a brownish inner colour.
doi:10.1371/journal.pone.0045008.g004
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normalizing signal intensities towards the contralateral blood
signal.
Thus, we concluded that LIBS-MPIO is a suitable approach for
detecting early and small atherothrombosis in mice. The low
threshold of detection (2% of the vascular lumen) suggests that the
LIBS-MPIO strategy should be efficient at detecting vulnerable/
unstable atherosclerotic plaques.
Other approaches are currently under investigation for detect-
ing vulnerable plaques. For example, a radionuclide-based strategy
ex vivo detected the glycoprotein VI exposed by endothelium injury
in carotid arteries [21]. A non contrast-enhanced T1-weighted
MRI of methemoglobin detected intracoronary thrombi in
patients [22]. However, methemoglobin is also present in plaque
hemorrhages and may be the source of false positive signals. MRI
contrast agents targeting activated platelets have the theoretical
advantage to be more specific. A fibrin-targeted peptide [23,24]
and a cyclic RGD peptide coupled to Gadolinium [25] are
promising alternativestrategies for imaging thrombosis. However,
our present study is the first to show efficiency at detecting
specifically atherothrombosis directly in vivo.
Gawaz et al. reported the efficiency of soluble GPVI to identify
arterial lesions induced by a wire in ApoE2/2 mice [26] or by ex
vivo ballooning in rabbits [27]. These studies confirmed the
previously shown role for GPVI in thrombosis, i.e. GPVI is
required in the process of platelet recruitment under physiological
shear stress in vivo. Therefore the feasibility of detecting
thrombosis in its amplification stage was established in models
mimicking vascular injury (wire-induced injury) or atherosclerotic
plaque (ballooning). In addition, the GPVI strategy might detect
also nascent thrombosis when it is triggered by collagen. Our
findings add to these data with two important elements: first, we
show the feasibility of detecting thrombosis generated by murine
Figure 5. Quantification of MPIOs on histological sections.MPIOs were about four-fold more abundant in animals with LIBS-MPIO-injection as
compared to the animals receiving control-MPIO. A similar difference was observed between injured and non injured vessels in animals receiving
LIBS-MPIO. Correlation of thrombus size with the number of bound MPIOs in animals with LIBS-MPIO injection is not significant; however the number
of MPIOs is in average within a similar range of 10–20 MPIOs per section as expected from the observed signal attenuation.
doi:10.1371/journal.pone.0045008.g005
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plaques, itself induced by hypercholesterolemia, as it is the case
with human atherosclerosis. Second, our approach is different in
regards to the molecular mechanism being targeted, because we
used an antibody recognizing the final response of platelet
activation and thus LIBS is able to recognize/detect athero-
thrombosis as soon as thrombosis is initiated, independent on the
actual platelet stimulation pathway. Whether this difference is
clinically relevant warrants further investigations.
Our results have some limitations that need to be considered.
First, the scratching model does not provide ‘‘standardized’’ extent
of atherothrombosis, since it depends mainly upon the plaque
thrombogenicity, which is variable. In 7 of 20 cases animals had to
be excluded from statistics because of a full occlusion led to a total
blood signal void already in the baseline scans. Conversely, this
variability in the atherothrombotic response is a good indication
that this model is close to clinical pictures with plaque rupture and
vessel occlusion.
Another limitation towards translation to human applications is
the negative contrast generated by iron oxide based contrast
agents. Iron oxides provide a reliable diagnosis only if native
images express a hyper-intense signal which is altered by the
contrast agent. However, ongoing research in MR methodology
aiming for ‘‘white marker sequences’’ [28,29] and the new
technique of magnetic particle imaging [30] provide the potential
to overcome these technical drawback. These new methodologies
in combination with the LIBS targeting strategy should allow early
detection of unstable atherosclerotic plaques in humans.
In conclusion, our studies provide the first proof of principle
that atherothrombosis induced by murine plaque rupture can be
detected by LIPS-MPIO. This detection was highly sensitive and
constitutes therefore an important perspective for early detection
of atherothrombosis in clinic and improvement in prevention of
myocardial infarction.
Acknowledgments
The authors thank the IGBMC, Institut de Ge´ne´tique et de Biologie
Mole´culaire et Cellulaire for assistance.
Author Contributions
Conceived and designed the experiments: DvE, CvzM, KP, CB, JEF.
Performed the experiments: DvE, CvzM, KW, IN, AZ, MM, PT, ALC,
JEF. Analyzed the data: DvE, CvzM, JEF, CB, KW, AZ, MM.
Contributed reagents/materials/analysis tools: MM, PT, ALC, IN, AZ.
Wrote the paper: DvE, CvzM, CB, JEF, KP.
References
1. Corti R, Farkouh ME, Badimon JJ (2002) The vulnerable plaque and acute
coronary syndromes. Am J Med 113: 668–680.
2. Gross S, Tilly P, Hentsch D, Vonesch JL, Fabre JE (2007) Vascular wall-
produced prostaglandin E2 exacerbates arterial thrombosis and atherothrom-
bosis through platelet EP3 receptors. J Exp Med 204: 311–320.
3. Hamm CW, Bassand JP, Agewall S, Bax J, Boersma E, et al. (2011) ESC
Guidelines for the management of acute coronary syndromes in patients
presenting without persistent ST-segment elevation. European Heart Journal 32:
2999–3054.
4. Stone GW, Maehara A, Lansky AJ, de BB, Cristea E, et al. (2011) A prospective
natural-history study of coronary atherosclerosis. N Engl J Med 364: 226–235.
5. Rogers IS, Nasir K, Figueroa AL, Cury RC, Hoffmann U, et al. (2010)
Feasibility of FDG imaging of the coronary arteries: comparison between acute
coronary syndrome and stable angina. JACC Cardiovasc Imaging 3: 388–397.
6. Choudhury RP, Fisher EA (2009) Molecular imaging in atherosclerosis,
thrombosis, and vascular inflammation. Arterioscler Thromb Vasc Biol 29:
983–991.
7. Rogers WJ, Prichard JW, Hu YL, Olson PR, Benckart DH, et al. (2000)
Characterization of signal properties in atherosclerotic plaque components by
intravascular MRI. Arterioscler Thromb Vasc Biol 20: 1824–1830.
8. Choudhury RP, Fuster V, Fayad ZA (2004) Molecular, cellular and functional
imaging of atherothrombosis. Nat Rev Drug Discov 3: 913–925.
9. von zur Muhlen C, von Elverfeldt D, Moeller JA, Choudhury RP, Paul D, et al.
(2008) Magnetic resonance imaging contrast agent targeted toward activated
platelets allows in vivo detection of thrombosis and monitoring of thrombolysis.
Circulation 118: 258–267.
10. von zur Muhlen C, von ED, Choudhury RP, Ender J, Ahrens I, et al. (2008)
Functionalized magnetic resonance contrast agent selectively binds to glycopro-
tein IIb/IIIa on activated human platelets under flow conditions and is
detectable at clinically relevant field strengths. Mol Imaging 7: 59–67.
11. von zur Muhlen C, Sibson NR, Peter K, Campbell SJ, Wilainam P, et al. (2008)
A contrast agent recognizing activated platelets reveals murine cerebral malaria
pathology undetectable by conventional MRI. J Clin Invest 118: 1198–1207.
12. von zur Muhlen C, Peter K, Ali ZA, Schneider JE, McAteer MA, et al. (2009)
Visualization of activated platelets by targeted magnetic resonance imaging
utilizing conformation-specific antibodies against glycoprotein IIb/IIIa. J Vasc
Res 46: 6–14.
13. Schwarz M, Katagiri Y, Kotani M, Bassler N, Loeffler C, et al. (2004)
Reversibility versus persistence of GPIIb/IIIa blocker-induced conformational
change of GPIIb/IIIa (alphaIIbbeta3, CD41/CD61). J Pharmacol Exp Ther
308: 1002–1011.
14. Stoll P, Bassler N, Hagemeyer CE, Eisenhardt SU, Chen YC, et al. (2007)
Targeting ligand-induced binding sites on GPIIb/IIIa via single-chain antibody
allows effective anticoagulation without bleeding time prolongation. Arterioscler
Thromb Vasc Biol 27: 1206–1212.
15. Schwarz M, Meade G, Stoll P, Ylanne J, Bassler N, et al. (2006) Conformation-
specific blockade of the integrin GPIIb/IIIa: a novel antiplatelet strategy that
selectively targets activated platelets. Circ Res 99: 25–33.
16. Getz GS, Reardon CA (2006) Diet and Murine Atherosclerosis. Arterioscler
Thromb Vasc Biol 26: 242–249.
17. Shapiro EM, Skrtic S, Koretsky AP (2005) Sizing it up: cellular MRI using
micron-sized iron oxide particles. Magn Reson Med 53: 329–338.
18. Shapiro EM, Sharer K, Skrtic S, Koretsky AP (2006) In vivo detection of single
cells by MRI. Magn Reson Med 55: 242–249.
19. Gawaz M, Langer H, May AE (2005) Platelets in inflammation and
atherogenesis. J Clin Invest 115: 3378–3384.
20. Gawaz M (2004) Role of platelets in coronary thrombosis and reperfusion of
ischemic myocardium. Cardiovasc Res 61: 498–511.
21. Langer HF, Haubner R, Pichler BJ, Gawaz M (2008) Radionuclide imaging: a
molecular key to the atherosclerotic plaque. J Am Coll Cardiol 52: 1–12.
22. Jansen CH, Perera D, Makowski MR, Wiethoff AJ, Phinikaridou A, et al. (2011)
Detection of intracoronary thrombus by magnetic resonance imaging in patients
with acute myocardial infarction. Circulation 124: 416–424.
23. Sirol M, Aguinaldo JG, Graham PB, Weisskoff R, Lauffer R, et al. (2005) Fibrin-
targeted contrast agent for improvement of in vivo acute thrombus detection
with magnetic resonance imaging. Atherosclerosis 182: 79–85.
24. Sirol M, Fuster V, Badimon JJ, Fallon JT, Moreno PR, et al. (2005) Chronic
thrombus detection with in vivo magnetic resonance imaging and a fibrin-
targeted contrast agent. Circulation 112: 1594–1600.
25. Klink A, Lancelot E, Ballet S, Vucic E, Fabre JE, et al. (2010) Magnetic
resonance molecular imaging of thrombosis in an arachidonic acid mouse model
using an activated platelet targeted probe. Arterioscler Thromb Vasc Biol 30:
403–410.
26. Gawaz M, Konrad I, Hauser AI, Sauer S, Li Z, et al. (2005) Non-invasive
imaging of glycoprotein VI binding to injured arterial lesions. Thromb Haemost
93: 910–913.
27. Bigalke B, Lindemann S, Sch+Aˆnberger T, Pohlmeyer I, Chiribiri A, et al.
(2011) Ex vivoimaging of injured arteries in rabbits using fluorescence-labelled
glycoprotein VI-Fc. Platelets 23: 1–6.
28. Dharmakumar R, Koktzoglou I, Li D (2006) Generating positive contrast from
off-resonant spins with steady-state free precession magnetic resonance imaging:
theory and proof-of-principle experiments. Phys Med Biol 51: 4201–4215.
29. Patil S, Jirak D, Saudek F, Hajek M, Scheffler K (2011) Positive contrast
visualization of SPIO-labeled pancreatic islets using echo-dephased steady-state
free precession. Eur Radiol 21: 214–220.
30. Weizenecker J, Gleich B, Rahmer J, Dahnke H, Borgert J (2009) Three-
dimensional real-time in vivo magnetic particle imaging. Phys Med Biol 54: L1–
L10.
MR Imaging of In Vivo Atherothrombosis in Mice
PLOS ONE | www.plosone.org 8 September 2012 | Volume 7 | Issue 9 | e45008
